Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roberto Daniel Gonzalez Benitez"'
Autor:
Alfonso Ariza, Iustina Janta, L. Valor, Belén Serrano-Benavente, Carlos M. González-Fernández, José María Álvaro-Gracia, Juan Gabriel Ovalles Bonilla, Francisco Javier López-Longo, Roberto Daniel Gonzalez Benitez, Julia Martínez-Barrio, Juan Carlos Nieto-González, Tamara Del Río Blasco, Indalecio Monteagudo
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 28(1)
The aims of this study were to describe the long-term retention rate of golimumab (GLM) treatment in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and spondyloarthritis (SpA) in real life, and to analyze determinants of disconti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a10e18170e0b7bb28363e5bd2fc15b37
https://pubmed.ncbi.nlm.nih.gov/33492028
https://pubmed.ncbi.nlm.nih.gov/33492028
Autor:
Belén Atienza-Mateo, Esteban Rubio Romero, Ricardo Blanco, Miguel A. González-Gay, Luis Fernández-Dominguez, B. Joven-Ibáñez, Beatriz Arca, Alfonso Corrales, Clara Ventin-Rodriguez, José Luis Martín-Varillas, Jose Campos Esteban, Antia Crespo Golmar, Francisco Ortiz-Sanjuán, Maria Jose Moreno, Manuel Moreno, Eva Galindez, O. Maíz, Rafael Melero, Agusti Sellas-Fernández, Raul Veroz Gonzalez, Enrique Raya, Roberto Daniel Gonzalez Benitez, Olga Rusinovich, Alejandro Escudero Contreras, Emma Beltrán, Vanesa Calvo-Río, Natalia Palmou-Fontana, Javier Loricera, Ximena Elizabeth Larco Rojas, María-Luisa Peral
Publikováno v:
Abstracts accepted for Publication.
Background: Tofacitinib (TOFA) is the first inhibitor of JAK kinases with approval for the treatment of psoriatic arthritis (PsA) in Europe (July 2018)1. ToFA has shown efficacy in refractory patients to anti-TNF2. Objectives: A) to assess efficacy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bacfa1479a5769dfa23f37f5a822b1c
https://doi.org/10.1136/annrheumdis-2019-eular.7803
https://doi.org/10.1136/annrheumdis-2019-eular.7803
Autor:
Amparo Lopez Esteban, Roberto Daniel Gonzalez Benitez, Aurora Alonso Amigo, Juan Carlos Sanchez Zanotti, Florentina García Calle, Juan Carlos Nieto, Beln Serrano Benavente, Juan Ovalles, Tamara Del Río Blasco, Alfonso Ariza, Carlos Gonzalez, Indalecio Monteagudo Sez
Publikováno v:
HPR Epidemiology and public health (including prevention).
Background In patients with rheumatic diseases, suicidal ideation (Si) and suicide attempt (Sa) have been observed more frequently than in the general population. Objectives 1. To determine the prevalence of Si and Sa in patients with biological ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a56c0b186bcdd8afe63ce475430822
https://doi.org/10.1136/annrheumdis-2019-eular.6887
https://doi.org/10.1136/annrheumdis-2019-eular.6887
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.